atreca
present
upcoming
virtual
investor
conferences
south
san
francisco
globe
newswire
atreca
atreca
nasdaq
bcel
biotechnology
company
focused
developing
novel
therapeutics
generated
unique
discovery
platform
based
interrogation
active
human
immune
response
today
announced
participate
following
upcoming
virtual
investor
conferences
cowen
next
io
summit
friday
november
fireside
chat
time
est
stifel
virtual
healthcare
conference
wednesday
november
fireside
chat
time
est
evercore
isi
annual
healthconx
wednesday
december
panel
discussion
time
est
title
finders
keepers
identifying
new
cancer
targets
live
audio
webcasts
cowen
stifel
presentations
accessed
events
presentations
section
company
website
archived
replay
webcast
available
company
website
days
following
live
presentations
atreca
atreca
biopharmaceutical
company
developing
novel
immunotherapeutics
generated
differentiated
discovery
platform
atreca
platform
allows
access
unexplored
landscape
oncology
identification
unique
pairs
generated
human
immune
system
active
immune
response
tumors
antibodies
provide
basis
therapeutic
candidates
lead
product
candidate
phase
study
evaluating
multiple
solid
tumor
cancers
currently
enrolling
patients
information
atreca
please
visit
contacts
atreca
herb
cross
chief
financial
officer
info
investors
alex
gray
agray
